​

Larimar Therapeutics (LRMR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Larimar Therapeutics Revenue Highlights

00

Larimar Therapeutics Revenue by Period

Larimar Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Larimar Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Larimar Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$241.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--

Larimar Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Larimar Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CHRSCoherus BioSciences$266.96M$7.60M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
ALECAlector$100.56M$54.24M
STROSutro Biopharma$62.04M$14.81M
SPROSpero Therapeutics$47.98M$9.36M
MRUSMerus$36.13M$9.14M
SNDXSyndax Pharmaceuticals$23.68M$20.04M
SRZNSurrozen$10.65M$655.00K
BOLTBolt Biotherapeutics$7.69M$1.22M
KROSKeros Therapeutics$3.55M$3.04M
IKNAIkena Oncology--
IMRXImmuneering--
CABACabaletta Bio--
PCVXVaxcyte--
KZRKezar Life Sciences--
CNTACentessa Pharmaceuticals--
CELCCelcuity--
LRMRLarimar Therapeutics--

LRMR Revenue FAQ

What is Larimar Therapeutics’s yearly revenue?

Larimar Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. LRMR's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Larimar Therapeutics’s quarterly revenue?

Larimar Therapeutics's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $241K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). LRMR's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Larimar Therapeutics’s revenue growth rate?

Larimar Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.